Home |  Elder Rights |  Health |  Pension Watch |  Rural Aging |  Armed Conflict |  Aging Watch at the UN  

  SEARCH SUBSCRIBE  
 

Mission  |  Contact Us  |  Internships  |    

 



back

Some related articles :

Want to support Global Action on Aging?

Click below:

Thanks!

 

Insurer Pushes Use of Generic Drugs As Cost-Cutter

  Buffalo News

 September 20, 2002 

Wearing buttons that read "Go Generic! The Smart Choice," representatives of Blue Cross/Blue Shield of Western New York introduced a new educational campaign Tuesday during a news conference at the Rite Aid Pharmacy on Main Street in Williamsville.

The campaign is aimed at consumers, as well as doctors and pharmacists.

Blue Cross officials were joined by representatives from the AARP and the office of Sen. Charles E. Schumer, D-N.Y.

The AARP has a national advertising campaign called "Check Up on Your Prescriptions" that encourages consumers to consider generic drugs, and Schumer has co-sponsored a bill with Sen. John McCain, R- Ariz., aimed at lowering the costs of prescription drugs. The legislation would remove loopholes that slow the introduction of generic drugs into the marketplace.

Consumers often are influenced by heavy advertising of brand- name drugs, which represent about 55 percent of the prescription drug market, said Renee Fleming, vice president of Blue Cross/Blue Shield of Western New York.

"The sense is that people are hesitant to use generics because they think they're inferior," Fleming said.

Nonetheless, generic drugs go through the same Food and Drug Administration approval process as brand-name drugs, said Ed Stevens, a pharmacist with Rite Aid Corp., which is supporting the campaign.

"We're 100 percent behind it. We see the savings that are available, and the savings are dramatic," Stevens said. "The drugs are going through the same FDA testing. There's no question about their safety and efficacy."

A generic drug is made with the same active ingredients and is available in the same strength and dosage as the equivalent brand- name product. They cost less because generic manufacturers spend far less on research, development, sales and marketing.

The average cost of a generic prescription in 2001 was $21.96, about 31 percent of the $71.18 it cost, on average, to fill a brand- name medication, according to the National Association of Chain Drug Stores.

Blue Cross/Blue Shield, which has about 570,000 subscribers in Western New York, figures that it would save $3 million for each percentage-point increase in usage of generic drugs rather than brand names.

Consumers would benefit from lower out-of-pocket costs at the pharmacy and could also save money on insurance premiums by choosing generic drugs, because insurers pass the high cost of brand-name drugs on to subscribers, said Fleming, who was in Albany on Monday to introduce the campaign to consumers there.

Independent Health, which has about 360,000 members, said the campaign would help other insurers and health maintenance organizations, spokesman Frank Sava said.

"We certainly all can benefit from that," Sava said.

Independent Health has focused on "benefit design and physician education" rather than public awareness in trying to increase the use of generic drugs, said John Rodgers, director of pharmacy.

In January, the HMO moved to a three-tier co-payment system that charges a $7 co-pay for generic drugs, $15 for preferred brand names, and $30 for nonpreferred brand names. "We're really phasing out the flat co-pay," Rodgers said.

The new tier system already has helped reverse a trend that began in 1997 toward decreased use of generic drugs, he added.

Blue Cross's campaign would consist primarily of working with doctors and pharmacists in educating the public, Fleming said.


Copyright © 2002 Global Action on Aging
Terms of Use  |  Privacy Policy  |  Contact Us